AMICUS THERAPEUTICS, INC.
CFO
7 appearances
Latest appearance 2025-05-01
Simon Harford
CFO
AMICUS THERAPEUTICS, INC.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Simon Harford
Simon Harford is recorded as CFO at AMICUS THERAPEUTICS, INC.. AMICUS THERAPEUTICS, INC. reported in an 8-K filed April 27, 2026 that Simon Harford resigned as executive officer, effective April 27, 2026. AMICUS THERAPEUTICS, INC. reported in an 8-K filed August 21, 2023 that Simon Harford was appointed Chief Financial Officer (principal financial officer), effective August 21, 2023. The proxy statement of AMICUS THERAPEUTICS, INC. reports total compensation of $3,449,065 for Simon Harford in fiscal 2024, including a base salary of $514,423. Disclosed compensation is on record for 3 fiscal years. Simon Harford has spoken on 7 earnings calls across 1 company, most recently for AMICUS THERAPEUTICS, INC. on May 1, 2025.
“In connection with the consummation of the Merger, as of the Effective Time, all executive officers of the Company immediately prior to the Effective Time (Bradley L. Campbell, Simon Harford, Ellen S. Rosenberg, David M. Clark and Jeffrey P. Castelli) ceased to be executive officers of the Surviving Corporation.”
“On August 17, 2023, the Board of Directors (the "Board") of Amicus Therapeutics, Inc. (the "Company") appointed Simon Harford as the Chief Financial Officer (principal financial officer) of the Company, effective as of August 21, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
AMICUS THERAPEUTICS, INC.
CFO
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | AMICUS THERAPEUTICS, INC. | Chief Financial Officer | $514,423 | $3,449,065 |
| 2023 | AMICUS THERAPEUTICS, INC. | Chief Financial Officer | $173,077 | $2,980,585 |
| 2022 | AMICUS THERAPEUTICS, INC. | Chief Financial Officer | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
-
Earnings call
AMICUS THERAPEUTICS, INC. Q1 FY2025 Earnings Call
AMICUS THERAPEUTICS, INC.
-
Earnings call
AMICUS THERAPEUTICS, INC. Q4 FY2024 Earnings Call
AMICUS THERAPEUTICS, INC.
-
Earnings call
AMICUS THERAPEUTICS, INC. Q3 FY2024 Earnings Call
AMICUS THERAPEUTICS, INC.
-
Earnings call
AMICUS THERAPEUTICS, INC. Q2 FY2024 Earnings Call
AMICUS THERAPEUTICS, INC.
-
Earnings call
AMICUS THERAPEUTICS, INC. Q1 FY2024 Earnings Call
AMICUS THERAPEUTICS, INC.
-
Earnings call
AMICUS THERAPEUTICS, INC. Q4 FY2023 Earnings Call
AMICUS THERAPEUTICS, INC.
-
Earnings call
AMICUS THERAPEUTICS, INC. Q3 FY2023 Earnings Call
AMICUS THERAPEUTICS, INC.
-
Executive change Appointed: Chief Financial Officer (principal financial officer)
AMICUS THERAPEUTICS, INC.